These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35326699)

  • 1. Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care.
    Tu SM; Guo CC; Chow DS; Zacharias NM
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell Theory of Cancer: Rude Awakening or Bad Dream from Cancer Dormancy?
    Tu SM; Estecio MR; Lin SH; Zacharias NM
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curing Cancer: Lessons from a Prototype.
    Tu SM; Pisters LL
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity.
    Tu SM; Zhang M; Wood CG; Pisters LL
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrono-Drug Discovery and Development Based on Circadian Rhythm of Molecular, Cellular and Organ Level.
    Ohdo S
    Biol Pharm Bull; 2021; 44(6):747-761. PubMed ID: 34078807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense.
    Sun M; Yang C; Zheng J; Wang M; Chen M; Le DQS; Kjems J; Bünger CE
    Acta Biomater; 2015 Dec; 28():171-182. PubMed ID: 26415776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
    Begicevic RR; Falasca M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Multidrug Resistance in Cancer Stem Cells.
    Moitra K
    Biomed Res Int; 2015; 2015():635745. PubMed ID: 26649310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment.
    Luan S; Zeng X; Zhang C; Qiu J; Yang Y; Mao C; Xiao X; Zhou J; Zhang Y; Yuan Y
    Front Cell Dev Biol; 2021; 9():664816. PubMed ID: 33816512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench.
    Tu SM; Singh SR; Arnaoutakis K; Malapati S; Bhatti SA; Joon AY; Atiq OT; Pisters LL
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.
    Nedeljković M; Damjanović A
    Cells; 2019 Aug; 8(9):. PubMed ID: 31443516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNAs in cancer chemoresistance: The sword and the shield.
    Mondal P; Meeran SM
    Noncoding RNA Res; 2021 Dec; 6(4):200-210. PubMed ID: 34977437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
    Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
    Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.
    Gaggianesi M; Di Franco S; Pantina VD; Porcelli G; D'Accardo C; Verona F; Veschi V; Colarossi L; Faldetta N; Pistone G; Bongiorno MR; Todaro M; Stassi G
    Front Oncol; 2021; 11():702642. PubMed ID: 34354950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells and chemosensitivity.
    Maugeri-Saccà M; Vigneri P; De Maria R
    Clin Cancer Res; 2011 Aug; 17(15):4942-7. PubMed ID: 21622723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronopharmacological strategies focused on chrono-drug discovery.
    Ohdo S; Koyanagi S; Matsunaga N
    Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.